Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.47 |
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | PPARA | Q07869 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.47 |
| ▸ | CYSLTR2 | Q9NS75 | 15/20 | 0.46 |
| ▸ | CYSLTR1 | Q9Y271 | 15/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2924329 | 0.86 | MMP2 (0.46) | PPARAGRM2KMT2A | |
| SCHEMBL480388 | 0.82 | CYP1A2 (0.50) | PPARGPPARDPPARALMNACYP1A2 | |
| SCHEMBL30736074 | 0.82 | CYP1A2 (0.50) | PPARGPPARDPPARALMNACYP1A2 | |
| SCHEMBL6932259 | 0.81 | PPARG (0.48) | PPARGPPARDPPARALMNACYP1A2 | |
| SCHEMBL13452821 | 0.81 | PPARG (0.48) | PPARGPPARDPPARALMNACYP1A2 | |
| SCHEMBL481237 | 0.79 | GRM2 (0.50) | PPARGPPARDPPARALMNACYP1A2 | |
| SCHEMBL8672731 | 0.79 | NOS2 (0.38) | CYP1A2MAPTCYP2C9MEN1GLA | |
| SCHEMBL9177662 | 0.78 | CYSLTR2 (0.50) | PPARGPPARDPPARALMNACYP1A2 | |
| SCHEMBL7041417 | 0.78 | CYP1A2 (0.47) | PPARGPPARDPPARALMNACYP1A2 | |
| SCHEMBL7968145 | 0.77 | CYSLTR2 (0.49) | PPARGPPARDPPARALMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2441762-A1 | Potentiators of Glutamate Receptors | Eli Lilly and Company (US) | 2012-04-18 | — | — | EP | disclosed |
| EP-1817301-B1 | POTENTIATORS OF GLUTAMATE RECEPTORS | LILLY CO ELI (US) | 2012-02-01 | — | — | EP | disclosed |
| US-7816523-B2 | Potentiators of glutamate receptors | ELI LILLY AND COMPANY (US) | 2010-10-19 | — | — | US | disclosed |
| US-7803938-B2 | Potentiators of glutamate receptors | ELI LILLY AND COMPANY (US) | 2010-09-28 | — | — | US | disclosed |
| US-20090318481-A1 | Potentiators Of Glutamate Receptors | AICHER THOMAS DANIEL | 2009-12-24 | — | — | US | disclosed |
| US-20090318483-A1 | Potentiators Of Glutamate Receptors | AICHER THOMAS DANIEL | 2009-12-24 | — | — | US | disclosed |
| US-7598423-B2 | Potentiators of glutamate receptors | ELI LILLY AND COMPANY (US) | 2009-10-06 | — | — | US | disclosed |
| US-20080139505-A1 | Potentiators Of Glutamate Receptors | ARRAY BIOPHARMA, INC. | 2008-06-12 | — | — | US | disclosed |
| EP-1817301-A1 | POTENTIATORS OF GLUTAMATE RECEPTORS | ELI LILLY AND COMPANY (US) | 2007-08-15 | — | — | EP | disclosed |
| WO-2006057870-A1 | POTENTIATORS OF GLUTAMATE RECEPTORS | ELI LILLY AND COMPANY (US) | 2006-06-01 | — | — | WO | disclosed |
| EP-0150966-B1 | BENZOPYRAN DERIVATIVES, COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION | FISONS plc (GB) | 1989-07-12 | — | — | EP | disclosed |
| US-4698345-A | Quinoline derivatives and their use as anti-asthmatic agents | FISONS PLC (GB) | 1987-10-06 | — | — | US | disclosed |
| EP-0077090-B1 | PROCESS FOR THE PRODUCTION OF QUINOLINE CONTAINING HETEROCYCLES, INTERMEDIATES, AND PROCESS FOR THE PRODUCTION OF THE INTERMEDIATES | FISONS plc (GB) | 1986-01-15 | — | — | EP | disclosed |
| EP-0150966-A2 | Benzopyran derivatives, compositions containing them and processes for their preparation | FISONS plc (GB) | 1985-08-07 | — | — | EP | disclosed |
| US-4419352-A | ANTIALLERGENS; ANTI SECRETORY AGENTS; MUCUS | FISONS LIMITED (GB) | 1983-12-06 | — | — | US | disclosed |
| US-4356181-A | Anti-allergic mono salt of 6-methylamino-4-oxo-10-propyl-4H-pyrano[3,2-g]-quinoline-2,8-dicarboxylic acid | FISONS LIMITED (GB) | 1982-10-26 | — | — | US | disclosed |
| EP-0037187-A1 | Salts and aqueous solutions of 6-methylamino-4-oxo-10-propyl-4H-pyrano(3,2-g)-quinoline-2,8-di-carboxylic acid and pharmaceutical compositions containing such salts and solutions | FISONS plc (GB) | 1981-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139505-A1 | Potentiators Of Glutamate Receptors | GRM1, GRIN1, GRM2 | PPARG 321/4885PPARD 471/4885PPARA 632/4885 |
| US-20090318481-A1 | Potentiators Of Glutamate Receptors | GRIK1, GRIK2, GRIK4 | PPARG 580/4885PPARD 854/4885PPARA 926/4885 |
| US-20090318483-A1 | Potentiators Of Glutamate Receptors | GRIK1, GRIK2, GRIK4 | PPARG 580/4885PPARD 854/4885PPARA 926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.